Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Microalbuminuria and urinary albumin excretion in clinical practice].

Tagle R, González F, Acevedo M.

Rev Med Chil. 2012 Jun;140(6):797-805. doi: 10.4067/S0034-98872012000600016. Review. Spanish.

2.

Microalbuminuria as a marker of cardiovascular risk in patients with type 2 diabetes.

Erdmann E.

Int J Cardiol. 2006 Feb 15;107(2):147-53. Epub 2005 Jun 22. Review.

PMID:
15975669
3.

Microalbuminuria and urinary albumin excretion: French clinical practice guidelines.

Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D.

Diabetes Metab. 2007 Sep;33(4):303-9. Epub 2007 Aug 16.

PMID:
17702622
4.

Urinary albumin to osmolality ratio predicts 24-hour urine albumin excretion in diabetes mellitus.

Gyamlani GG, Bergstralh EJ, Slezak JM, Larson TS.

Am J Kidney Dis. 2003 Oct;42(4):685-92.

PMID:
14520618
5.

Treatment of microalbuminuria in patients with type 2 diabetes mellitus.

Jerums G, MacIsaac RJ.

Treat Endocrinol. 2002;1(3):163-73. Review.

PMID:
15799209
7.

[Microalbuminuria and urinary albumin excretion: clinical practice guidelines].

Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D.

Nephrol Ther. 2007 Oct;3(6):384-91. Epub 2007 Aug 10. French.

PMID:
17919641
8.

Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study.

Morikawa A, Ishizeki K, Iwashima Y, Yokoyama H, Muto E, Oshima E, Sekiguchi M, Miura T, Itoh H, Haneda M.

Clin Exp Nephrol. 2011 Dec;15(6):848-53. doi: 10.1007/s10157-011-0512-3. Epub 2011 Aug 9.

PMID:
21823043
9.

Practical aspects of measuring microalbuminuria in diabetic patients.

Jermendy G, Farkas K, Nádas J, Daróczy A, Péterfai E.

Diabetes Nutr Metab. 2001 Aug;14(4):195-200.

PMID:
11716288
10.

The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: therapeutic implications.

Chiarelli F, Verrotti A, Mohn A, Morgese G.

Ann Med. 1997 Oct;29(5):439-45. Review.

PMID:
9453292
11.

[Microalbuminuria and urinary albumin excretion: French guidelines].

Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D; French Society of Nephrology.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):277-84. doi: 10.1684/abc.2008.0229. French.

12.

Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

Diabetes Care. 1999 Jul;22(7):1176-80.

13.

Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects.

Chaiken RL, Khawaja R, Bard M, Eckert-Norton M, Banerji MA, Lebovitz HE.

Diabetes Care. 1997 May;20(5):709-13.

PMID:
9135931
14.

Albuminuria: a target for treatment of type 2 diabetic nephropathy.

de Zeeuw D.

Semin Nephrol. 2007 Mar;27(2):172-81. Review.

PMID:
17418686
16.

Short-term variability and sampling distribution of various parameters of urinary albumin excretion in patients with non-insulin-dependent diabetes mellitus.

Smulders YM, Slaats EH, Rakic M, Smulders FT, Stehouwer CD, Silberbusch J.

J Lab Clin Med. 1998 Jul;132(1):39-46.

PMID:
9665370
17.
18.
19.

Ethnic differences in correlates of microalbuminuria in NIDDM. The role of the acute-phase response.

Islam N, Kazmi F, Chusney GD, Mattock MB, Zaini A, Pickup JC.

Diabetes Care. 1998 Mar;21(3):385-8.

PMID:
9540020
20.

[Validity of the first morning urine collection for screening for microalbuminuria in the diabetic].

Signorini AM, Fondelli C, Tanganelli I, Pallassini A, Gragnoli G.

Boll Soc Ital Biol Sper. 1989 Aug;65(8):719-25. Italian.

PMID:
2803735

Supplemental Content

Support Center